The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis

被引:2
|
作者
Sun, Meixia [1 ]
Ding, Yi [2 ]
Chen, Kang [1 ]
He, Yanwen [1 ]
Zhang, Yukun [1 ]
Zhuo, Yue [1 ]
Zhuang, He [1 ,3 ]
机构
[1] Shandong Univ Tradit Chinese Med, Sch Rehabil Med, Jinan, Shandong, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Affiliated Hosp 2, Jinan, Shandong, Peoples R China
[3] Shandong Univ Tradit Chinese Med, Sch Rehabil Med, Jinan 250300, Shandong, Peoples R China
关键词
acute myocardial infarction; lead therapy; meta-analysis; percutaneous coronary intervention;
D O I
10.1097/MD.0000000000036183
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To systematically evaluate the effects of lead therapies on percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI).Methods: A randomized controlled trial (RCT) in the CNKI, Wanfang, VIP, ProQuest, PubMed, Cochrane Library, Scopus, and Web of Science databases was searched until January 2023. Two researchers strictly screened and checked the included literature, extracted relevant data, and used the Cochrane Manual to assess the risk quality of the literature. Using RevMan 5.3 software, Meta-analysis of 4 main outcome measures [cardiac function-related indicators, 6-minute walking distance (6 MWT), quality of life (SF-36), Seattle angina pectoris scale (SAQ)], and 3 secondary outcome measures [adverse event incidence, death incidence, and readmission rate].Results: 22 studies were finally included with 1754 subjects, but the overall quality of the included studies was not high. The results of the meta-analysis showed that, in the cardiac function-related indicators compared to controls, improved left ventricular ejection fraction (LVEF) index (MD = 1.42, 95%CI [-0.94, 3.79], P < .00001); however, compared with the Baduanjin group, Tai Chi ball + Baduanjin group and control group, there was no significant difference (P > .05); compared with the control group, the guidance therapy group improved the left ventricular end-diastolic volume (LVEDV) index (MD = -4.67, 95%CI [-6.8, -2.71], P < .00001). In comparison, the lead group improved the 6 MWT (MD = 69.44, 95%CI [30.12, 108.76], P < .00001); the SF-36 score (MD = 10.05, 95%CI [8.68, 11.42], P < .00001])and the SAQ score (MD = 6.2, 95%CI [3.97, 8.44], P < .00001). Among the secondary outcome measures, the incidence of adverse events was statistically significant (RR = 0.17, 95%CI [0.1, 0.32], P < .00001); statistically significant (RR = 0.29, 95%CI (0.1, 0.87), P < .00001); readmission (RR = 0.39, 95%CI [0.17, 0.87, 0.89], P < .00001).Conclusion: Based on the current study, combining conventional therapy/ exercise or using simple lead therapy after PCI can improve the treatment effect and improve the quality of life.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Therapeutic Effects of Empagliflozin in Diabetic Patients After Acute Myocardial Infarction: Systematic Review and Meta-Analysis With Trial Sequential Analysis
    Mouffokes, Adel
    Soliman, Youssef
    Amer, Basma E.
    Umar, Tungki Pratama
    Abdelazeem, Basel
    CIRCULATION, 2023, 148
  • [22] Complete Revascularization Techniques for Acute Myocardial Infarction: A Systematic Review and Meta-Analysis Comparing Angiography- and Coronary Physiology-Guided PCI
    Zhang, Yanyan
    Zhou, Zuoyi
    Zheng, Bo
    Gong, Yanjun
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2025, 2025 (01)
  • [23] Therapeutic effects and safety of early use of sacubitril/valsartan after acute myocardial infarction: a systematic review and meta-analysis
    Zhang, Li
    Yan, Kun
    Zhao, Hanru
    Shou, Yunfeng
    Chen, Tong
    Chen, Jianfei
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (03) : 1017 - 1027
  • [24] The incidence of stroke after myocardial infarction: A meta-analysis
    Witt, BJ
    Ballman, KV
    Brown, RD
    Meverden, RA
    Jacobsen, SJ
    Roger, VL
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (04): : 354.e1 - 354.e9
  • [25] Beta-blocker therapy in acute myocardial infarction: A meta-analysis of clinical trials
    Shah, AP
    Ebrahimi, R
    Wadhani, N
    Toggart, EJ
    Rubin, SA
    CIRCULATION, 2005, 112 (17) : U493 - U493
  • [26] A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction
    Mamas, Mamas A.
    Neyses, Ludwig
    Fath-Ordoubadi, Farzin
    EXPERIMENTAL & CLINICAL CARDIOLOGY, 2010, 15 (02) : E20 - E24
  • [27] Hypothermia therapy for the treatment of acute myocardial infarction A protocol for systematic review and meta-analysis
    Jiang, Fen
    Zeng, Defei
    Xing, Kongyu
    Yang, Xiaoli
    MEDICINE, 2021, 100 (38)
  • [28] The efficacy and safety of Empagliflozin on outcomes of patients with myocardial infarction undergoing primary PCI: a systematic review and meta-analysis
    Alizadehasl, Azin
    Hakimian, Hoda
    Abdolkarimi, Leyla
    Afsari Zonooz, Yasamin
    Amini-Salehi, Ehsan
    Hosseini Jebelli, Seyedeh Fatemeh
    Yalameh Aliabadi, Azam
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, : 4969 - 4977
  • [29] The Safety and Efficacy of the Early Use of Sacubitril/Valsartan After Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials
    Abdullah
    Rashid, Majid
    Jeffrey Soto, Cuauhtemoc
    Virk, Ghazala S.
    Mekowulu, Favour C.
    Chaudhari, Sandipkumar S.
    Batool, Saima
    Usama, Muhammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [30] Impella® in cardiogenic shock after acute myocardial infarction: a systematic review and meta-analysis
    Vargas, Kris G.
    Geppert, Alexander
    Huber, Kurt
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : 274 - 275